IP Library Granted Patent US 9,002,652
Granted Patent B1
US 9,002,652 · App. 11/342,366 · Granted Apr 7, 2015

Methods for identifying and using organ-specific proteins in blood

Inventors: Leroy Hood (Seattle, WA); Biaoyang Lin (Bothell, WA)
Assignee: Institute for Systems Biology
G01N33/68G01N33/6893G06K9/00127
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,002,652
App. No.
11/342,366
Granted
Apr 7, 2015
Kind
B1
Abstract

The present invention relates generally to methods for identifying organ-specific secreted proteins and for identifying organ-specific molecular blood fingerprints therefrom. As such, the present invention provides compositions comprising such proteins, detection reagents for detecting such proteins, and panels, and arrays for determining organ-specific molecular blood fingerprints.

Claims (15)

1. A method for identifying a set of at least 5 organ-specific proteins that are specifically produced in a preselected organ and are shed into the blood comprising,

(a) determining, using mRNA transcripts, the sequences of sequences 17-20 nucleotides long that have been identified as signature sequences characteristic of mRNA transcripts that encode proteins from substantially all mRNA transcripts isolated from a sample of said preselected organ;

(b) comparing, using a computer, the signature sequences to a database of known RNA transcripts to identify the mRNA transcripts that encode proteins to obtain a preliminary set of mRNA transcripts;

(c) comparing, using a computer, the identified mRNA transcripts to mRNA transcripts known to be expressed in other organs;

(d) removing, using a computer, from said preliminary set any mRNA transcripts that are known to be substantially expressed in other organs thus obtaining an intermediate set of mRNA transcripts;

(e) identifying, using a computer, from the remaining mRNA transcripts in the intermediate set those mRNA transcripts that include a sequence encoding a signal peptide, thereby identifying transcripts that encode organ-specific secreted proteins from said preselected organ; and

(f) confirming, using a blood sample, the presence of the organ-specific secreted proteins by assessing the blood sample, thereby identifying a set of at least 5 organ-specific proteins from said preselected organ that are shed into blood.

2. The method of claim 1 wherein one of said at least 5 organ-specific proteins identified is carboxypeptidase E precursor (CPE) having SEQ ID NO:1520 or olfactory receptor, family 51, subfamily E, member 2 (OR51e2) having SEQ ID NO:1740.

3. A method for identifying a set of at least 5 organ-specific proteins that are specifically produced in a preselected organ and are shed into the blood comprising,

(a) determining, using mRNA transcripts, the sequences of sequences 17-20 nucleotides long that have been identified as signature sequences characteristic of mRNA transcripts that encode proteins from substantially all mRNA transcripts isolated from a sample of said preselected organ;

(b) comparing, using a computer, the signature sequences to a database of known RNA transcripts to identify the mRNA transcripts that encode proteins to obtain a preliminary set of mRNA transcripts;

(c) identifying, using a computer, from among the mRNA transcripts identified in (b) as encoding proteins, those mRNA transcripts that are expressed in the preselected organ at a level at least 2.5 times the level of expression of the same mRNA transcripts observed in other organs;

(d) identifying, using a computer, from the transcripts in (c) those transcripts that include a sequence encoding a signal peptide, thereby identifying transcripts that encode organ-specific proteins secreted or shed into the blood; and

(e) confirming, using a blood sample, the presence of the organ-specific secreted proteins by assessing the blood sample thereby identifying a set of at least 5 organ-specific proteins shed into blood.

4. The method of claim 3 wherein an identified organ-specific protein is carboxypeptidase E precursor (CPE) having SEQ ID NO:1520 or olfactory receptor, family 51, subfamily E, member 2 (OR51e2) having SEQ ID NO:1740.

Assignments (4)
SECURITY AGREEMENT Recorded Nov 22, 2022
From: BIODESIX, INC.
To: PERCEPTIVE CREDIT HOLDINGS IV, LP
Reel/Frame 061977/0919 →
RELEASE OF SECURITY INTEREST Recorded Aug 12, 2020
From: IND FUNDING LLC
To: INTEGRATED DIAGNOSTICS, INC.
Reel/Frame 053476/0137 →
SECURITY INTEREST IN RIGHTS UNDER A LICENSE AGREEMENT IN WHICH LISTED PATENTS ARE LICENSED Recorded Apr 29, 2014
From: INTEGRATED DIAGNOSTICS, INC.
To: IND FUNDING LLC
Reel/Frame 032785/0261 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2006
From: HOOD, LEROY; LIN, BIAOYANG
To: INSTITUTE FOR SYSTEMS BIOLOGY
Reel/Frame 017588/0518 →
Continuity (2)
Provisional Application 60647685 · Jan 27, 2005
Provisional Application 60683071 · May 20, 2005